Se

Name: Listerine
Brand: Listerine
Availability: InStock
Rating: 3.8 (5 reviews)

Many people who chew tobacco or dip snuff think it's safer than smoking. But you don't have to smoke tobacco for it to be dangerous. Chewing or dipping carries risks like:

Cancer of the mouth
Decay of exposed tooth roots
Pulling away of the gums from the teeth
White patches or red sores in the mouth that can turn to cancer

Recent research shows the dangers of smokeless tobacco may go beyond the mouth. It might also play a role in other cancers, heart disease and stroke.

Smokeless tobacco contains more nicotine than cigarettes. Nicotine is a highly addictive drug that makes it hard to stop using tobacco once you start. Having a quit date and a quitting plan can help you stop successfully.

NIH: National Institute of Dental and Craniofacial Research

Se FDA Approved Drugs

ABILIFY MAINTENA KIT [Aripiprazole^{C₂₃H₂₇Cl₂N₃O₂}]

300mg (intramuscular for suspension, extended release)

300mg/vial (intramuscular for suspension, extended release)

400mg (intramuscular for suspension, extended release)

400mg/vial (intramuscular for suspension, extended release)

Otsuka Pharm Co Ltd^{Sep 29, 2014}

Treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia.
Treatment of schizophrenia.
Use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia.
Use of aripiprazole in extended release injectable suspension.

ABSTRAL [Fentanyl Citrate^{C₂₂H₂₈N₂OC₆H₈O₇}]

eq 0.1mg base (sublingual tablet)

eq 0.2mg base (sublingual tablet)

eq 0.3mg base (sublingual tablet)

eq 0.4mg base (sublingual tablet)

eq 0.6mg base (sublingual tablet)

eq 0.8mg base (sublingual tablet)

Sentynl Theraps Inc^{Jan 7, 2011}

Management of breakthrough pain in patients with cancer.

ACARBOSE [Acarbose^{C₂₅H₄₃NO₁₈}]

100mg (oral tablet)

25mg (oral tablet)

50mg (oral tablet)

Emcure Pharms Ltd^{Feb 7, 2012}
Impax Labs^{May 14, 2009}
Mylan^{Jan 6, 2011}
Strides Pharma^{Jul 27, 2011}
Virtus Pharm^{Oct 17, 2013}
Watson Labs^{May 7, 2008}
West-ward Pharms Int^{May 7, 2008}

ACCUNEB [Albuterol Sulfate^{2C₁₃H₂₁NO₃H₂O₄S}]

eq 0.021% base (inhalation solution)

eq 0.042% base (inhalation solution)

Mylan Speciality Lp^{Apr 30, 2001}

Indicated for the relief of bronchospasm in patients 2-12 years of age with asthma (reversible obstructive airway disease).

ACEBUTOLOL HYDROCHLORIDE [Acebutolol Hydrochloride^{C₁₈H₂₈N₂O₄ClH}]

eq 200mg base (oral capsule)

eq 400mg base (oral capsule)

Amneal Pharm^{Dec 30, 1999}
Mylan^{Apr 24, 1995}

ACETADOTE [Acetylcysteine^{C₅H₉NO₃S}]

6gm/30ml (200mg/ml) (intravenous injectable)

Cumberland Pharms^{Jan 23, 2004}

Composition and method for providing a reduction in side effects for human patients in need of acetylcysteine therapy.
Method of treating acetaminophen overdose with acetylcysteine solutions.

ACTIQ [Fentanyl Citrate^{C₂₂H₂₈N₂OC₆H₈O₇}]

eq 0.2mg base (transmucosal troche/lozenge)

eq 0.4mg base (transmucosal troche/lozenge)

eq 0.6mg base (transmucosal troche/lozenge)

eq 0.8mg base (transmucosal troche/lozenge)

eq 1.2mg base (transmucosal troche/lozenge)

eq 1.6mg base (transmucosal troche/lozenge)

Cephalon^{Nov 4, 1998}

ACTONEL [Risedronate Sodium^{C₇H₁₀NO₇P₂Na}]

150mg (oral tablet)

30mg (oral tablet)

35mg (oral tablet)

Apil^{Apr 22, 2008}

35 mg orally once a week for prevention of osteoporosis in postmenopausal women; 35 mg orally once a week for treatment of osteoporosis in postmenopausal women.
Prevention and treatment of osteoporosis.
Treatment of osteoporosis in postmenopausal women.

ACTOPLUS MET XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

1gm : eq 15mg base (oral tablet, extended release)

1gm : eq 30mg base (oral tablet, extended release)

Takeda Pharms Usa^{May 12, 2009}

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with pioglitazone and metformin or who have inadequate glycemic control on pioglitazone or metformin alone.
Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with a pioglitazone and metformin.
To reduce gastrointestinal side effects administer with a meal; as starting dose administer once daily with evening meal.

ACTOS [Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

eq 15mg base (oral tablet)

eq 30mg base (oral tablet)

eq 45mg base (oral tablet)

Takeda Pharms Usa^{Jul 15, 1999}

Method of reducing side effects of active components admin to a diabetic by admin a chemical compound having formula (incl pioglitazone) in combination with an insulin secretion enhancer.

ACULAR [Ketorolac Tromethamine^{C₁₅H₁₃NO₃C₄H₁₁NO₃}]

0.5% (ophthalmic solution/drops)

Allergan^{Nov 9, 1992}

ACULAR LS [Ketorolac Tromethamine^{C₁₅H₁₃NO₃C₄H₁₁NO₃}]

0.4% (ophthalmic solution/drops)

Allergan^{May 30, 2003}

A method of controlling postoperative ocular pain and burning/stinging in a patient.
A method of treating ocular pain and/or enhancing ocular comfort.
A method of treating ocular pain.
A method of treating or preventing ocular pain and burning.
A method of treating or preventing ocular pain and burning/stinging following corneal surgery.
A method of treating or preventing ocular pain in a patient.
A method of treating or reducing ocular pain and burning/stinging.

ACUVAIL [Ketorolac Tromethamine^{C₁₅H₁₃NO₃C₄H₁₁NO₃}]

0.45% (ophthalmic solution/drops)

Allergan^{Jul 22, 2009}

ACYCLOVIR SODIUM [Acyclovir Sodium^{C₈H₁₀N₅O₃Na}]

eq 1gm base/vial (injection injectable)

eq 500mg base/vial (injection injectable)

eq 50mg base/ml (injection injectable)

Hikma Pharms Llc^{Feb 29, 2016}
Mylan Labs Ltd^{Mar 29, 2017}
Zydus Pharms Usa Inc^{Jun 13, 2017}
Fresenius Kabi Usa^{Apr 30, 1998}
Aurobindo Pharma Ltd^{Oct 11, 2013}

ADAGEN [Pegademase Bovine^{C₅H₈NO₃(C₂H₄O)n}]

250 units/ml (injection injectable)

Sigma Tau^{Mar 21, 1990}

ADDYI [Flibanserin^{C₂₀H₂₁F₃N₄O}]

100mg (oral tablet)

Sprout Pharms^{Aug 18, 2015}

Use of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat hypoactive sexual desire disorder (hsdd).

ADEFOVIR DIPIVOXIL [Adefovir Dipivoxil^{C₂₀H₃₂N₅O₈P}]

10mg (oral tablet)

Sigmapharm Labs Llc^{Aug 29, 2013}

ADLYXIN [Lixisenatide]

0.15mg/3ml (0.05mg/ml) (subcutaneous solution)

0.3mg/3ml (0.1mg/ml) (subcutaneous solution)

Sanofi-aventis Us^{Jul 27, 2016}

Combination treatment with a glitazone for improvement of glycemic control in type 2 diabetes mellitus patients.
Improvement in glycemic control in type 2 diabetes mellitus patients by use of a pen injector.

ADVIL ALLERGY SINUS [Chlorpheniramine Maleate^{C₁₆H₁₉ClN₂C₄H₄O₄} : Ibuprofen^{C₁₃H₁₈O₂} : Pseudoephedrine Hydrochloride^{C₁₀H₁₅NOClH}]

OTC

2mg : 200mg : 30mg (oral tablet)

Pfizer^{Dec 19, 2002}

ADVIL COLD AND SINUS [Ibuprofen^{C₁₃H₁₈O₂} : Pseudoephedrine Hydrochloride^{C₁₀H₁₅NOClH}]

OTC

200mg : 30mg (oral tablet)

eq 200mg free acid and potassium salt : 30mg (oral capsule)

Pfizer^{Sep 19, 1989}

AFINITOR [Everolimus^{C₅₃H₈₃NO₁₄}]

10mg (oral tablet)

2.5mg (oral tablet)

7.5mg (oral tablet)

Novartis^{Mar 30, 2009}

Treatment of advanced hormone receptor positive, her2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
Treatment of patients with progessive neuroendocrine tumors of pancreatic origin (pnet) that are unresectable, locally advanced or metastatic.
Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..
Treatment of solid excretory system tumors; advanced renal cell carcinoma (rcc), after failure of treatment with sunitinib or sorafenib.

AFINITOR DISPERZ [Everolimus^{C₅₃H₈₃NO₁₄}]

2mg (oral tablet, for suspension)

3mg (oral tablet, for suspension)

5mg (oral tablet, for suspension)

Novartis Pharm^{Aug 29, 2012}

Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..

AFIRMELLE [Ethinyl Estradiol^{C₂₀H₂₄O₂} : Levonorgestrel^{C₂₁H₂₈O₂}]

0.02mg : 0.1mg (oral-28 tablet)

Aurobindo Pharma Ltd^{Nov 14, 2016}

AFREZZA [Insulin Recombinant Human]

12 units/inh (inhalation powder)

4 units/inh (inhalation powder)

8 units/inh (inhalation powder)

Mannkind^{Apr 17, 2015}

Administration of a composition comprising insulin complexed with a diketopiperazine..
Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
Administration of fdkp microparticles comprising insulin..
Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
Pulmonary administration of a composition comprising insulin bound to a complexing agent..
Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
Use of an inhaler to administer dry powder medicament.

AFRINOL [Pseudoephedrine Sulfate^{2C₁₀H₁₅NOH₂O₄S}]

OTC

120mg (oral tablet, extended release)

Schering Plough^{Approved Prior To Jan 1, 1982}

AKNE-MYCIN [Erythromycin^{C₃₇H₆₇NO₁₃}]

2% (topical ointment)

Dow Pharm^{Jan 10, 1985}

AKTEN [Lidocaine Hydrochloride^{C₁₄H₂₂N₂OClHH₂O}]

3.5% (ophthalmic gel)

Akorn^{Oct 7, 2008}

Method of inducing topical anesthesia in the eye.

AKYNZEO [Netupitant^{C₃₀H₃₂F₆N₄O} : Palonosetron Hydrochloride^{C₁₉H₂₄N₂OClH}]

300mg : eq 0.5mg base (oral capsule)

Helsinn Hlthcare^{Oct 10, 2014}

Prevention of chemotherapy-induced nausea and vomiting.

ALA-CORT [Hydrocortisone^{C₂₁H₃₀O₅}]

1% (topical cream)

2.5% (topical cream)

Crown Labs^{Approved Prior To Jan 1, 1982}

ALA-SCALP [Hydrocortisone^{C₂₁H₃₀O₅}]

2% (topical lotion)

Crown Labs^{Approved Prior To Jan 1, 1982}

ALAVERT [Loratadine^{C₂₂H₂₃ClN₂O₂}]

OTC

10mg (oral tablet, orally disintegrating)

Pfizer^{Dec 19, 2002}

ALEVE-D SINUS & COLD [Naproxen Sodium^{C₁₄H₁₃O₃Na} : Pseudoephedrine Hydrochloride^{C₁₀H₁₅NOClH}]

OTC

200mg : 120mg (oral tablet, extended release)

Bayer^{Nov 29, 1999}

ALIMTA [Pemetrexed Disodium^{C₂₀H₁₉N₅O₆2Na}]

eq 100mg base/vial (iv (infusion) injectable)

eq 500mg base/vial (iv (infusion) injectable)

Lilly^{Sep 7, 2007}

Pretreatment of patients with vitamin b12 and folic acid prior to pemetrexed disodium administration.
Use of pemetrexed with prior and/or repeated vitamin b12 and folic acid administration.

ALINIA [Nitazoxanide^{C₁₂H₉N₃O₅S}]

100mg/5ml (oral for suspension)

500mg (oral tablet)

Romark^{Nov 22, 2002}

Method of treating infection by cryptosporidium parvum in an immunocompromised mammal.

ALLEGRA [Fexofenadine Hydrochloride^{C₃₂H₃₉NO₄ClH}]

30mg/5ml (oral suspension)

Sanofi Aventis Us^{Oct 16, 2006}

Relief of symptoms associated with seasonal allergic rhinitis in children 2 to 11 years and for the relief of symptoms associated with uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 11 years.

ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION [Fexofenadine Hydrochloride^{C₃₂H₃₉NO₄ClH} : Pseudoephedrine Hydrochloride^{C₁₀H₁₅NOClH}]

OTC

60mg : 120mg (oral tablet, extended release)

Sanofi Aventis Us^{Jan 24, 2011}

Relief of symptoms associated with respiratory allergies, swelling of the nasal passages and sinus congestion and pressure in adults and children 12 years of age and older.

ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION [Fexofenadine Hydrochloride^{C₃₂H₃₉NO₄ClH} : Pseudoephedrine Hydrochloride^{C₁₀H₁₅NOClH}]

OTC

180mg : 240mg (oral tablet, extended release)

Sanofi Aventis Us^{Jan 24, 2011}

Relief of symptoms associated with respiratory allergies, swelling of the nasal passages and sinus congestion and pressure in adults and children 12 years of age and older.

ALLZITAL [Acetaminophen^{C₈H₉NO₂} : Butalbital^{C₁₁H₁₆N₂O₃}]

325mg : 25mg (oral tablet)

Larken Labs Inc^{Dec 4, 2015}

ALOSETRON HYDROCHLORIDE [Alosetron Hydrochloride^{C₁₇H₁₈N₄OClH}]

eq 0.5mg base (oral tablet)

eq 1mg base (oral tablet)

Amneal Pharms^{Dec 22, 2016}
West-ward Pharms Int^{May 4, 2015}

ALOXI [Palonosetron Hydrochloride^{C₁₉H₂₄N₂OClH}]

eq 0.075mg base/1.5ml (eq 0.05mg base/ml) (intravenous injectable)

eq 0.25mg base/5ml (eq 0.05mg base/ml) (intravenous injectable)

Helsinn Hlthcare^{Feb 29, 2008}

Prevention of chemotherapy-induced nausea and vomiting.

ALPROSTADIL [Alprostadil^{C₂₀H₃₄O₅}]

0.5mg/ml (injection injectable)

Teva Pharms Usa^{Apr 30, 1999}
West-ward Pharms Int^{Jan 20, 1998}

ALTAVERA [Ethinyl Estradiol^{C₂₀H₂₄O₂} : Levonorgestrel^{C₂₁H₂₈O₂}]

0.03mg : 0.15mg (oral-28 tablet)

Sandoz^{Aug 3, 2010}

ALTOPREV [Lovastatin^{C₂₄H₃₆O₅}]

20mg (oral tablet, extended release)

40mg (oral tablet, extended release)

60mg (oral tablet, extended release)

Covis Pharma Bv^{Jun 26, 2002}

Method of decreasing the production of a-beta using a composition which decreases blood cholesterol in patients at risk of or exhibiting symptoms of alzheimer's disease.

ALUNBRIG [Brigatinib^{C₂₉H₃₉ClN₇O₂P}]

30mg (oral tablet)

90mg (oral tablet)

Ariad^{Apr 28, 2017}

Treatment of patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc) who have progressed on or are intolerant to crizotinib.

ALVESCO [Ciclesonide^{C₃₂H₄₄O₇}]

0.08mg/inh (inhalation aerosol, metered)

0.16mg/inh (inhalation aerosol, metered)

Takeda Gmbh^{Jan 10, 2008}

Maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. patent claims method for treating a respiratory disease in a child.
Method of treating inflammatory conditions.

ALYACEN 1/35 [Ethinyl Estradiol^{C₂₀H₂₄O₂} : Norethindrone^{C₂₀H₂₆O₂}]

0.035mg : 1mg (oral-28 tablet)

Glenmark Generics^{Jan 19, 2012}

ALYACEN 7/7/7 [Ethinyl Estradiol^{C₂₀H₂₄O₂} : Norethindrone^{C₂₀H₂₆O₂}]

0.035mg,0.035mg,0.035mg : 0.5mg,0.75mg,1mg (oral-28 tablet)

Glenmark Generics^{Jan 19, 2012}

AMELUZ [Aminolevulinic Acid Hydrochloride^{C₅H₉NO₃ClH}]

10% (topical gel)

Biofrontera^{May 10, 2016}

Treatment of actinic keratoses by photodynamic therapy.

AMINO ACIDS [Amino Acids]

15%(150gm/1000ml) (injection injectable)

15%(300gm/2000ml) (injection injectable)

B Braun^{Apr 13, 2012}

AMINOSYN 10% [Amino Acids]

10% (10gm/100ml) (injection injectable)

Icu Medical Inc^{Approved Prior To Jan 1, 1982}

AMINOSYN 10% (PH6) [Amino Acids]

10% (10gm/100ml) (injection injectable)

Icu Medical Inc^{Nov 18, 1985}

AMINOSYN 3.5% [Amino Acids]

3.5% (3.5gm/100ml) (injection injectable)

Icu Medical Inc^{Approved Prior To Jan 1, 1982}

AMINOSYN 5% [Amino Acids]

5% (5gm/100ml) (injection injectable)

Icu Medical Inc^{Approved Prior To Jan 1, 1982}

AMINOSYN 7% [Amino Acids]

7% (7gm/100ml) (injection injectable)

Icu Medical Inc^{Approved Prior To Jan 1, 1982}

AMINOSYN 7% (PH6) [Amino Acids]

7% (7gm/100ml) (injection injectable)

Icu Medical Inc^{Nov 18, 1985}

AMINOSYN 8.5% [Amino Acids]

8.5% (8.5gm/100ml) (injection injectable)

Icu Medical Inc^{Approved Prior To Jan 1, 1982}

AMINOSYN 8.5% (PH6) [Amino Acids]

8.5% (8.5gm/100ml) (injection injectable)

Icu Medical Inc^{Nov 18, 1985}

AMINOSYN II 10% [Amino Acids]

10% (10gm/100ml) (injection injectable)

Icu Medical Inc^{Apr 3, 1986}

AMINOSYN II 10% IN PLASTIC CONTAINER [Amino Acids]

10% (10gm/100ml) (injection injectable)

Icu Medical Inc^{Dec 19, 1991}

AMINOSYN II 15% IN PLASTIC CONTAINER [Amino Acids]

15% (15gm/100ml) (injection injectable)

Icu Medical Inc^{Dec 19, 1991}

AMINOSYN II 7% [Amino Acids]

7% (7gm/100ml) (injection injectable)

Icu Medical Inc^{Apr 3, 1986}

AMINOSYN II 8.5% [Amino Acids]

8.5% (8.5gm/100ml) (injection injectable)

Icu Medical Inc^{Apr 3, 1986}

AMINOSYN-HBC 7% [Amino Acids]

7% (7gm/100ml) (injection injectable)

Icu Medical Inc^{Jul 12, 1985}

AMINOSYN-HF 8% [Amino Acids]

8% (8gm/100ml) (injection injectable)

Icu Medical Inc^{Apr 4, 1996}

AMINOSYN-PF 10% [Amino Acids]

10% (10gm/100ml) (injection injectable)

Icu Medical Inc^{Oct 17, 1986}

AMINOSYN-PF 7% [Amino Acids]

7% (7gm/100ml) (injection injectable)

Icu Medical Inc^{Sep 6, 1985}

AMINOSYN-RF 5.2% [Amino Acids]

5.2% (5.2gm/100ml) (injection injectable)

Icu Medical Inc^{Approved Prior To Jan 1, 1982}

AMITIZA [Lubiprostone^{C₂₀H₃₂F₂O₅}]

24mcg (oral capsule)

8mcg (oral capsule)

Sucampo Pharma Llc^{Jan 31, 2006}

Method for relieving constipation in a human patient that comprises administering to the patient a dosage unit comprising (i) 24mcg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient.
Method for relieving constipation in a patient with opioid-induced constipation that comprises administering to the patient a dosage unit comprising(i)24microg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient.
Method for relieving or treating constipation in a human constipated patient.
Method for relieving or treating constipation in a patient with irritable bowel syndrome.
Method for relieving or treating constipation in a patient with opioid-induced constipation.
Method for the long term treatment of chronic constipation in a human subject with irritable bowel syndrome.
Method for the long term treatment of chronic constipation in a human subject.
Method for treating constipation by opening cic channels in a mammalian subject.
Method for treating constipation in a patient with opioid-induced constipation by opening cic channels.
Method for treating irritable bowel syndrome and method for treating abdominal discomfort associated with irritable bowel syndrome.
Method for treating opioid-induced constipation.
Method of relieving or preventing constipation in a human constipated patient.
Method of relieving or preventing constipation in a human patient with opioid-induced constipation.
Method of treating constipation in a patient with irritable bowel syndrome by opening chloride channels (cic).
Method of treating constipation in a patient with irritable bowel syndrome.
Use in relieving or preventing constipation in a human patient with a dosage unit comprising 24microg+/- 10% of a drug substance and a pharmaceutically suitable excipient.
Use in relieving or preventing constipation in a patient with opioid-induced constipation with a dosage unit comprising 24microg +/- 10% of a drug substance and a pharmaceutically suitable excipient.

AMOXAPINE [Amoxapine^{C₁₇H₁₆ClN₃O}]

100mg (oral tablet)

150mg (oral tablet)

25mg (oral tablet)

Watson Labs^{Aug 28, 1992}

AMPHADASE [Hyaluronidase]

150 units/ml (injection injectable)

Amphastar Pharm^{Oct 26, 2004}

ANCEF IN PLASTIC CONTAINER [Cefazolin Sodium^{C₁₄H₁₃N₈O₄S₃Na}]

eq 10mg base/ml (injection injectable)

eq 20mg base/ml (injection injectable)

Baxter Hlthcare^{Mar 28, 1991}

ANDROGEL [Testosterone^{C₁₉H₂₈O₂}]

1.62% (20.25mg/1.25gm actuation) (transdermal gel, metered)

1.62% (20.25mg/1.25gm packet) (transdermal gel)

1.62% (40.5mg/2.5gm packet) (transdermal gel)

12.5mg/1.25gm actuation (transdermal gel, metered)

25mg/2.5gm packet (transdermal gel)

50mg/5gm packet (transdermal gel)

Abbvie^{Apr 29, 2011}

Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

ANECTINE [Succinylcholine Chloride^{C₁₄H₃₀N₂O₄2Cl}]

20mg/ml (injection injectable)

Sandoz Inc^{Approved Prior To Jan 1, 1982}

ANORO ELLIPTA [Umeclidinium Bromide^{C₂₉H₃₄NO₂Br} : Vilanterol Trifenatate^{C₂₄H₃₃Cl₂NO₅C₂₀H₁₆O₂}]

eq 0.0625mg base/inh : eq 0.025mg base/inh (inhalation powder)

Glaxosmithkline^{Dec 18, 2013}

Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Se

TOE NAIL FUNGUS [onychomycosis]
Mix equal parts brown Listerine antiseptic mouth wash and white vinegar. Soak feet in solution for 30 minutes daily until infection is cured.OscarWilde | November 4th, 2017

NAUSEA
Infuse fresh ginger with hot water, strain and freeze the liquid in ice cube trays. Break cubes into chips and suck on as needed.Jack | November 4th, 2017

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Se

Se FDA Approved Drugs

Home Remedies for Se